IL17A and hepatocellular carcinoma: IL-17A has been shown to promote the migration and invasion of HCC cells by increasing the expression of matrix metalloproteinases MMP2 and MMP9 through the NF-κB pathway and AKT2/STAT3 pathways (7, 132, 133).